Herbal Medicine Use and Safety Monitoring

Displaying 1 - 4 of 4CSV
Wang, E., Mathai, D. S., Gukasyan, N., Nayak, S., & Garcia-Romeu, A. (2024). Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-78736-1
Publication Date
Walsh, C. A., Livne, O., Shmulewitz, D., Stohl, M., & Hasin, D. S. (2022). Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002–2019. Addictive Behaviors Reports, 16, 100454. https://doi.org/10.1016/j.abrep.2022.100454
Publication Date
Hershman, D. L., Unger, J. M., Greenlee, H., Capodice, J., Lew, D. L., Darke, A., Minasian, L. M., Fisch, M. J., Henry, N. L., & Crew, K. D. (2022). Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain. JAMA Network Open, 5(11), e2241720. https://doi.org/10.1001/jamanetworkopen.2022.41720
Publication Date
Murray, L., Alexander, C., Bennett, C., Kuvaldina, M., Khalsa, G., & Fallon, B. (2022). Kundalini Yoga for Post-Treatment Lyme Disease: A Preliminary Randomized Study. Healthcare, 10(7), 1314. https://doi.org/10.3390/healthcare10071314
Publication Date